Neonatal anuria by ACE inhibitors during pregnancy

Nephron

Volumn 76, Issue 2, 1997, Pages 235-236

  Lavoratti, Giancarlo ^a   Seracini, Daniela ^a   Fiorini, Patrizio ^a   Cocchi, Cesare ^a   Materassi, Marco ^a   Donzelli, Giampaolo ^a   Pela, Ivana ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE; PENTETATE TECHNETIUM TC 99M;

ANURIA; APGAR SCORE; CASE REPORT; DRUG BLOOD LEVEL; ENZYME ACTIVITY; HUMAN; HYPOTENSION; INFANT; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; KIDNEY SCINTISCANNING; LETTER; MALE; MATERNAL HYPERTENSION; NEWBORN; OLIGOHYDRAMNIOS; PERITONEAL DIALYSIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; URINE VOLUME;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANURIA; CESAREAN SECTION; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; INFANT, NEWBORN; IODINE RADIOISOTOPES; KIDNEY; KIDNEY FAILURE, ACUTE; PEPTIDYL-DIPEPTIDASE A; PERITONEAL DIALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTER, THIRD; PRENATAL EXPOSURE DELAYED EFFECTS; TECHNETIUM TC 99M PENTETATE;

EID: 0030918402     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190179     Document Type: Article

References (9)

1. Matcrson BJ, Preston RA: Angiotensin-converting enzyme inhibitors in hypertension., Arch Med 1994;154:513-523.
2. Broughlon-Pipkin F., Baker PN., Syntonds EM: ACE inhibitors in pregnancy (letter)., Lancet 1989;vol ii:96-97.
3. Fiocchi R., Lijncn P., Staesscn J., et al: Captopril during pregnancy (letter)., Lancet 1984;vol ii:1153.
4. Hanssens M., Kcirse MJNC, Vankeleeom F., Van Asschc FA: Fetal and neonatal effects ot treatment with angiotensin-converting enzyme inhibitors in pregnancy., Obstet Gynecol 1991: 78:128-135.
5. Nightingale SL: Warnings on the use of ACE inhibitors in second and third trimester of pregnancy., JAMA 1992:267:2445.
6. Barr M., Cohen MM: ACE inhibitors, fetopathy and hypocalvaria: The kidney-skull connection., Teratology 1991:44:485-495.
7. Shotan A, Widerhorn J., Hurst A., Elkavam U: Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms and recommendation for use., Am J Med 1994:96:451-456.
8. Yosipiv IV., Dipp S., Eldahr SS: Ontogeny of somatic angiotensin-converting enzyme., Hypertension 1994:23:369-374.
9. Sedman AB, Kershaw DB., Bunchman TE: Recognition and management of angiotensin-convening enzyme inhibitors fetopathy., Pc-diatr Nephrol 1995:9:382-385